histology News

www.gastrotraining.com is an educational portal that aims to use innovations in technology to streamline the process of learning. We encourage our users to contribute as we feel that each of us has a role to play in training and education.

The histology test segment is one of the fastest growing sectors in the IVD industry. The growing market has attracted many new entrants and competition has intensified. Histology/cytology will grow annually 5-10% over the next 5-10 years.

This report reviews the key products dominating the Hematology IVD Market segment, the innovations that are occurring, and trends that are impacting the segment.

Global In-Vitro Diagnostics (IVD) market set to boom in the next seven years driven by ageing population

Milestone launches the TissueSAFE, a formalin-free vacuum packaging and transfer system for specimens originating from the surgical suite. Make your workplace safer, gain control of fixation start time, and allow flexibility for downstream testing.

MIS, Inc. has launched the latest PAXcam digital microscope camera, the PAXcamARC+. With 32 Megapixel imaging capability, and a low-light Scientific Grade CCD imager, this camera offers cutting-edge performance for science and industry.

New protein discovery gives chronic diarrhea patients hope. Many have been told it is all in their head, but this new research target may lead to help. Functional indicators and patient correlation are reasons for optimism.

World-Class Histology that improves pathology diagnosis through better quality. Improved protein preservation and 100X better image detail make slides easier to read and diagnosis more accurate. Research was never so enjoyable as with UltraLight.

New Melanin Bleach Kit removes melanin pigment in cells of malignant melanomas to clearly reveal cellular detail.

Milestone Medical’s MacroPATH D: Bringing the Histology Grossing Area into the Digital Era

Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report showing that cell-based diagnostics generated more than $6 billion last year.